Patent ID: 7122208

Claim:
A method for inhibiting the production of reactive oxygen species in a mammalian patient produced by neurological diseases selected from the group consisting of Down's syndrome, Huntington's disease, brain trauma and epilepsy, chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome, myasthenia gravis, dermatomyositis, polymyositis, inclusion body myositis, post stroke, neurosarcoidosis, vascular dementia, closed head trauma, vasospasm, subarachnoid hemorrhage, adrenal leukocytic dystrophy, inclusion body dermatomysitis, minimal cognitive impairment and duchenne muscular dystrophy, which method comprises: administering to said patient an aliquot of blood which has been treated ex vivo with at least two stressors selected from the group consisting of an oxidative environment, thermal stress and electromagnetic radiation; wherein the concentration of the reactive oxygen species in said patient is reduced.